Ascorbic acid, cognitive function, and Alzheimer's disease: A current review and future direction

BioFactors

Volumn 38, Issue 2, 2012, Pages 114-122

  Bowman, Gene L ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Ascorbic acid; Blood brain barrier; Blood CSF barrier; Choroid plexus; Cognitive function; CSF; Dementia; Plasma; SVCT; Vitamin C

Indexed keywords

ALPHA TOCOPHEROL; AMYLOID PRECURSOR PROTEIN; ANTIOXIDANT; ASCORBIC ACID; DNA;

AGED; AGING; ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; BLOOD CEREBROSPINAL FLUID BARRIER; BRAIN; BRAIN ATROPHY; BRAIN FUNCTION; BRAIN MITOCHONDRION; BRAIN TISSUE; CELL MEMBRANE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CHOROID PLEXUS; COGNITION; COGNITIVE DEFECT; DEMENTIA; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE COURSE; DNA DAMAGE; DRUG MEGADOSE; FOOD FREQUENCY QUESTIONNAIRE; HUMAN; LIPID PEROXIDATION; MINI MENTAL STATE EXAMINATION; NERVE CELL; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; NUTRITION; OXIDATIVE STRESS; PATHOGENESIS; PLASMA; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; VITAMIN METABOLISM;

ALZHEIMER DISEASE; ANIMALS; ASCORBIC ACID; BRAIN; COGNITION; HUMANS;

ANIMALIA;

EID: 84859436505     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1002     Document Type: Review

References (50)

1. Association Association. ( 2011) Alzheimer's disease facts and figures. Alzheimers Dement. 7, 208-244.
2. Brookmeyer, R., Johnson, E., Ziegler-Graham, K., and Arrighi, H. M. ( 2007) Forecasting the global burden of Alzheimer's disease. Alzheimers Dement. 3, 186-191.
3. Jack, C. R. Jr., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., and Trojanowski, J. Q. ( 2010) Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 9, 119-128.
4. Jack, C. R. Jr., Vemuri, P., Wiste, H. J., Weigand, S. D., Aisen, P. S., Trojanowski, J. Q., Shaw, L. M., Bernstein, M. A., Petersen, R. C., Weiner, M. W., and Knopman, D. S. ( 2011) Evidence for ordering of Alzheimer disease biomarkers. Arch. Neurol. 68, 1526-1535.
5. Lo, R. Y., Hubbard, A. E., Shaw, L. M., Trojanowski, J. Q., Petersen, R. C., Aisen, P. S., Weiner, M. W., and Jagust, W. J. ( 2011) Longitudinal change of biomarkers in cognitive decline. Arch. Neurol. 68, 1257-1266.
6. Trojanowski, J. Q., Vandeerstichele, H., Korecka, M., Clark, C. M., Aisen, P. S., Petersen, R. C., Blennow, K., Soares, H., Simon, A., Lewczuk, P., Dean, R., Siemers, E., Potter, W. Z., Weiner, M. W., Jack, C. R. Jr., Jagust, W., Toga, A. W., Lee, V. M., and Shaw, L. M. ( 2010) Update on the biomarker core of the Alzheimer's disease neuroimaging initiative subjects. Alzheimers Dement. 6, 230-238.
7. Gorelick, P. B., Scuteri, A., Black, S. E., Decarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., Petersen, R. C., Schneider, J. A., Tzourio, C., Arnett, D. K., Bennett, D. A., Chui, H. C., Higashida, R. T., Lindquist, R., Nilsson, P. M., Roman, G. C., Sellke, F. W., and Seshadri, S. ( 2011) Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke 42, 2672-2713.
8. Markesbery, W. R. ( 1999) The role of oxidative stress in Alzheimer disease. Arch. Neurol. 56, 1449-1452.
9. Polidori, M. C. and Mecocci, P. ( 2002) Plasma susceptibility to free radical-induced antioxidant consumption and lipid peroxidation is increased in very old subjects with Alzheimer disease. J. Alzheimers Dis. 4, 517-522.
10. Butterfield, D. A., Reed, T., Newman, S. F., and Sultana, R. ( 2007) Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. Free Radic. Biol. Med. 43, 658-677.
11. Sultana, R., Mecocci, P., Mangialasche, F., Cecchetti, R., Baglioni, M., and Butterfield, D. A. ( 2011) Increased protein and lipid oxidative damage in mitochondria isolated from lymphocytes from patients with Alzheimer's disease: insights into the role of oxidative stress in Alzheimer's disease and initial investigations into a potential biomarker for this dementing disorder. J. Alzheimers Dis. 24, 77-84.
12. Cutler, R. G., Kelly, J., Storie, K., Pedersen, W. A., Tammara, A., Hatanpaa, K., Troncoso, J. C., and Mattson, M. P. ( 2004) Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc. Natl. Acad. Sci. USA 101, 2070-2075.
13. Markesbery, W. R. and Lovell, M. A. ( 2007) Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment. Arch. Neurol. 64, 954-956.
14. Linus Pauling Insitute-Micronutrient Information Center. [Internet] Available at: Accessed on October 10, 2011.
15. Mandl, J., Szarka, A., and Banhegyi, G. ( 2009) Vitamin C: update on physiology and pharmacology. Br. J. Pharmacol. 157, 1097-1110.
16. Frei, B., England, L., and Ames, B. N. ( 1989) Ascorbate is an outstanding antioxidant in human blood plasma. Proc. Natl. Acad. Sci. USA 86, 6377-6381.
17. Vatassery, G. T. ( 1996) Oxidation of vitamin E, vitamin C, and thiols in rat brain synaptosomes by peroxynitrite. Biochem. Pharmacol. 52, 579-586.
18. Tallaksen, C. M., Bohmer, T., and Bell, H. ( 1992) Concentrations of the water-soluble vitamins thiamin, ascorbic acid, and folic acid in serum and cerebrospinal fluid of healthy individuals. Am. J. Clin. Nutr. 56, 559-564.
19. Quinn, J., Suh, J., Moore, M. M., Kaye, J., and Frei, B. ( 2003) Antioxidants in Alzheimer's disease-vitamin C delivery to a demanding brain. J. Alzheimers Dis. 5, 309-313.
20. Rice, M. E. ( 2000) Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci. 23, 209-216.
21. Nishikimi, M., Fukuyama, R., Minoshima, S., Shimizu, N., and Yagi, K. ( 1994) Cloning and chromosomal mapping of the human nonfunctional gene for L-gulono-gamma-lactone oxidase, the enzyme for L-ascorbic acid biosynthesis missing in man. J. Biol. Chem. 269, 13685-13688.
22. Agus, D. B., Gambhir, S. S., Pardridge, W. M., Spielholz, C., Baselga, J., Vera, J. C., and Golde, D. W. ( 1997) Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transporters. J. Clin. Invest. 100, 2842-2848.
23. Klepper, J., Vera, J. C., and De Vivo, D. C. ( 1998) Deficient transport of dehydroascorbic acid in the glucose transporter protein syndrome. Ann. Neurol. 44, 286-287.
24. Seidner, G., Alvarez, M. G., Yeh, J. I., O'Driscoll, K. R., Klepper, J., Stump, T. S., Wang, D., Spinner, N. B., Birnbaum, M. J., and De Vivo, D. C. ( 1998) GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier. Nat. Genet. 18, 188-191.
25. Tsukaguchi, H., Tokui, T., Mackenzie, B., Berger, U. V., Chen, X. Z., Wang, Y., Brubaker, R. F., and Hediger, M. A. ( 1999) A family of mammalian Na+-dependent L-ascorbic acid transporters. Nature 399, 70-75.
26. Spector, R. ( 2009) Nutrient transport systems in brain: 40 years of progress. J. Neurochem. 111, 315-320.
27. Skoog, I., Wallin, A., Fredman, P., Hesse, C., Aevarsson, O., Karlsson, I., Gottfries, C. G., and Blennow, K. ( 1998) A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia. Neurology 50, 966-971.
28. Bowman, G. L., Dodge, H., Frei, B., Calabrese, C., Oken, B. S., Kaye, J. A., and Quinn, J. F. ( 2009) Ascorbic acid and rates of cognitive decline in Alzheimer's disease. J. Alzheimers Dis. 16, 93-98.
29. Bowman, G. L., Kaye, J. A., Moore, M., Waichunas, D., Carlson, N. E., and Quinn, J. F. ( 2007) Blood-brain barrier impairment in Alzheimer disease: stability and functional significance. Neurology 68, 1809-1814.
30. Timpson, N. J., Forouhi, N. G., Brion, M. J., Harbord, R. M., Cook, D. G., Johnson, P., McConnachie, A., Morris, R. W., Rodriguez, S., Luan, J., Ebrahim, S., Padmanabhan, S., Watt, G., Bruckdorfer, K. R., Wareham, N. J., Whincup, P. H., Chanock, S., Sattar, N., Lawlor, D. A., and Davey Smith, G. ( 2010) Genetic variation at the SLC23A1 locus is associated with circulating concentrations of L-ascorbic acid (vitamin C): evidence from 5 independent studies with >15, 000 participants. Am. J. Clin. Nutr. 92, 375-382.
31. Morris, M. C., Beckett, L. A., Scherr, P. A., Hebert, L. E., Bennett, D. A., Field, T. S., and Evans, D. A. ( 1998) Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease. Alzheimer Dis. Assoc. Disord. 12, 121-126.
32. Masaki, K. H., Losonczy, K. G., Izmirlian, G., Foley, D. J., Ross, G. W., Petrovitch, H., Havlik, R., and White, L. R. ( 2000) Association of vitamin E and C supplement use with cognitive function and dementia in elderly men. Neurology 54, 1265-1272.
33. Grodstein, F., Chen, J., and Willett, W. C. ( 2003) High-dose antioxidant supplements and cognitive function in community-dwelling elderly women. Am. J. Clin. Nutr. 77, 975-984.
34. Zandi, P. P., Anthony, J. C., Khachaturian, A. S., Stone, S. V., Gustafson, D., Tschanz, J. T., Norton, M. C., Welsh-Bohmer, K. A., and Breitner, J. C., ( 2004) Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County study. Arch. Neurol. 61, 82-88.
35. Gray, S. L., Anderson, M. L., Crane, P. K., Breitner, J. C., McCormick, W., Bowen, J. D., Teri, L., and Larson, E. ( 2008) Antioxidant vitamin supplement use and risk of dementia or Alzheimer's disease in older adults. J. Am. Geriatr. Soc. 56, 291-295.
36. Morris, M. C., Evans, D. A., Bienias, J. L., Tangney, C. C., Bennett, D. A., Aggarwal, N., Wilson, R. S., and Scherr, P. A. ( 2002) Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA 287, 3230-3237.
37. Engelhart, M. J., Geerlings, M. I., Ruitenberg, A., van Swieten, J. C., Hofman, A., Witteman, J. C., and Breteler, M. M. ( 2002) Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 287, 3223-3229.
38. Luchsinger, J. A., Tang, M. X., Shea, S., and Mayeux, R. ( 2003) Antioxidant vitamin intake and risk of Alzheimer disease. Arch. Neurol. 60, 203-208.
39. Bowman, G. L., Shannon, J., Ho, E., Traber, M. G., Frei, B., Oken, B. S., Kaye, J. A., and Quinn, J. F. ( 2011) Reliability and validity of food frequency questionnaire and nutrient biomarkers in elders with and without mild cognitive impairment. Alzheimer Dis. Assoc. Disord. 25, 49-57.
40. Goodwin, J. S., Goodwin, J. M., and Garry, P. J. ( 1983) Association between nutritional status and cognitive functioning in a healthy elderly population. JAMA 249, 2917-2921.
41. Gale, C. R., Martyn, C. N., and Cooper, C. ( 1996) Cognitive impairment and mortality in a cohort of elderly people. BMJ 312, 608-611.
42. Riviere, S., Birlouez-Aragon, I., Nourhashemi, F., and Vellas, B. ( 1998) Low plasma vitamin C in Alzheimer patients despite an adequate diet. Int. J. Geriatr. Psychiatry 13, 749-754.
43. Charlton, K. E., Rabinowitz, T. L., Geffen, L. N., and Dhansay, M. A. ( 2004) Lowered plasma vitamin C, but not vitamin E, concentrations in dementia patients. J. Nutr. Health Aging 8, 99-107.
44. Polidori, M. C., Mattioli, P., Aldred, S., Cecchetti, R., Stahl, W., Griffiths, H., Senin, U., Sies, H., and Mecocci, P. ( 2004) Plasma antioxidant status, immunoglobulin g oxidation and lipid peroxidation in demented patients: relevance to Alzheimer disease and vascular dementia. Dement. Geriatr. Cogn. Disord. 18, 265-270.
45. Perrig, W. J., Perrig, P., and Stahelin, H. B. ( 1997) The relation between antioxidants and memory performance in the old and very old. J. Am. Geriatr. Soc. 45, 718-724.
46. Paraskevas, G. P., Kapaki, E., Libitaki, G., Zournas, C., Segditsa, I., and Papageorgiou, C. ( 1997) Ascorbate in healthy subjects, amyotrophic lateral sclerosis and Alzheimer's disease. Acta. Neurol. Scand. 96, 88-90.
47. Glaso, M., Nordbo, G., Diep, L., and Bohmer, T. ( 2004) Reduced concentrations of several vitamins in normal weight patients with late-onset dementia of the Alzheimer type without vascular disease. J. Nutr. Health Aging 8, 407-413.
48. Murakami, K., Murata, N., Ozawa, Y., Kinoshita, N., Irie, K., Shirasawa, T., and Shimizu, T. ( 2011) Vitamin C restores behavioral deficits and amyloid-beta oligomerization without affecting plaque formation in a mouse model of Alzheimer's disease. J. Alzheimers Dis. 26, 7-18.
49. Harrison, F. E., Hosseini, A. H., Dawes, S. M., Weaver, S., and May, J. M. ( 2009) Ascorbic acid attenuates scopolamine-induced spatial learning deficits in the water maze. Behav. Brain Res. 205, 550-558.
50. Harrison, F. E., May, J. M., and McDonald, M. P. ( 2010) Vitamin C deficiency increases basal exploratory activity but decreases scopolamine-induced activity in APP/PSEN1 transgenic mice. Pharmacol. Biochem. Behav. 94, 543-552.